Tumors of dysgenetic gonads (gonadoblastoma): ultrastructural and steroidogenic aspects.
D006907:17-alpha-Hydroxypregnenolone / Q000096:biosynthesis; D000735:Androstenedione / Q000096:biosynthesis; D000736:Androstenes / Q000096:biosynthesis; D001485:Basement Membrane / Q000648:ultrastructure; D002467:Cell Nucleus / Q000648:ultrastructure; D003593:Cytoplasm / Q000648:ultrastructure; D003687:Dehydroepiandrosterone / Q000096:biosynthesis; D004407:Dysgerminoma / Q000150:complications* / Q000378:metabolism / Q000648:ultrastructure; D004958:Estradiol / Q000096:biosynthesis; D004970:Estrone / Q000096:biosynthesis; D005260:Female; D012739:Gonadal Steroid Hormones / Q000096:biosynthesis*; D006801:Humans; D006908:Hydroxyprogesterones / Q000096:biosynthesis; D066298:In Vitro Techniques; D011284:Pregnenolone / Q000378:metabolism; D011374:Progesterone / Q000096:biosynthesis; D013739:Testosterone / Q000096:biosynthesis; D014424:Turner Syndrome / Q000150:complications*
D000736:Androstenes; D012739:Gonadal Steroid Hormones; D006908:Hydroxyprogesterones; D004970:Estrone; D006907:17-alpha-Hydroxypregnenolone; D013739:Testosterone; D000735:Androstenedione; D003687:Dehydroepiandrosterone; D011374:Progesterone; D004958:Estradiol; D011284:Pregnenolone